Variant report
Variant | esv1796502 |
---|---|
Chromosome Location | chr13:64222995-64236589 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576679370 | chr13:64223221-64223222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs146067680 | chr13:64223226-64223227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs367959298 | chr13:64223233-64223234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549381065 | chr13:64223240-64223241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562310284 | chr13:64223264-64223265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185239130 | chr13:64223267-64223268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541595702 | chr13:64223273-64223274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs535399108 | chr13:64223284-64223285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189629978 | chr13:64223301-64223302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547169046 | chr13:64223307-64223308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571981822 | chr13:64223327-64223328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs371466585 | chr13:64223344-64223345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532823165 | chr13:64223355-64223356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569281287 | chr13:64223360-64223361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs147849780 | chr13:64223361-64223362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537502090 | chr13:64223379-64223380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569184735 | chr13:64223390-64223391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs536631844 | chr13:64223405-64223406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs554804157 | chr13:64223531-64223532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566950710 | chr13:64223564-64223565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533741379 | chr13:64223576-64223577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs554525527 | chr13:64223580-64223581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538150280 | chr13:64223614-64223615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs376266842 | chr13:64223624-64223625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs576740811 | chr13:64223630-64223631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs537718090 | chr13:64223637-64223638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs370059423 | chr13:64223652-64223653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs372166188 | chr13:64223660-64223661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs542450774 | chr13:64223718-64223719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192353857 | chr13:64223727-64223728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183824264 | chr13:64223732-64223733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188151454 | chr13:64223740-64223741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571787357 | chr13:64223769-64223770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs377028118 | chr13:64223783-64223784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541806623 | chr13:64223845-64223846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs567968798 | chr13:64223865-64223866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs559994621 | chr13:64223870-64223871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs116412859 | chr13:64223907-64223908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540847061 | chr13:64223930-64223931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565453413 | chr13:64223940-64223941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs146980022 | chr13:64223996-64223997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs181475393 | chr13:64224004-64224005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563185710 | chr13:64224013-64224014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530083831 | chr13:64224034-64224035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563971299 | chr13:64224035-64224036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs138418162 | chr13:64224051-64224052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs148015726 | chr13:64224098-64224099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs141669169 | chr13:64224099-64224100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs2590921 | chr13:64224147-64224148 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs75429302 | chr13:64224169-64224170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:64223200-64224400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr13:64223600-64224200 | Enhancers | Brain Substantia Nigra | brain |
3 | chr13:64223800-64224200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr13:64224000-64224400 | Enhancers | H9 Cell Line | embryonic stem cell |
5 | chr13:64224400-64227200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr13:64227200-64227400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr13:64233000-64233600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr13:64235400-64235600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |